… Research projects from three biopharmaceutical companies in the United States comprise the 2013 second half … participants’ research projects are presented directly to industry groups who may wish to invest in further … Inc.’s study of XPro1595, which “turns off” inflammation to stop the loss of dopaminergic neurons and prevents disease …

… We recently formed a research team that comprises Parkinson’s scientists, immunologists, Crohn’s … disease experts, virologists and pathologists; this, to explore a function for LRRK2 in the immune system. … effect of some Parkinson’s-linked mutants (eg, G2019S) was shown to increase LRRK2’s kinase activity, which led to the …

… Objective/Rationale: Humans are exposed to agents and conditions that cause stress to dopaminergic … of Parkinson’s Disease: When ER stress becomes too great it induces death of cells. Our strategy is … sensitive to ER stress. Variability between cell lines, however, makes the results difficult to interpret at this …

… Foundation for Parkinson’s Research (MJFF) issued a grant to Verily, a company focused on health data platforms, to build upon the … gives the global scientific community another window into how Parkinson’s disease progresses over time, both in a …

… Editor’s note: Roseanne Dobkin, PhD, kindly authored this blog … disease (PD) the same way. Depression and anxiety are common and primary symptoms for many. While these symptoms … talk therapy is helpful, what it looks like in practice and how to find a good therapist. Let’s explore this and more …